Get the Stockscreener App
73.63
0.96%
0.70
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $73.63, with a volume of 994.11K.
It is up +0.96% in the last 24 hours and up +9.32% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$72.93
Open:
$72.8
24h Volume:
994.11K
Relative Volume:
0.47
Market Cap:
$35.59B
Revenue:
$10.63B
Net Income/Loss:
$819.00M
P/E Ratio:
44.42
EPS:
1.6577
Net Cash Flow:
$1.59B
1W Performance:
-0.84%
1M Performance:
+9.32%
6M Performance:
-10.89%
1Y Performance:
-7.01%
1-Day Range:
$72.64
$73.84
1-Week Range:
$72.43
$74.83
52-Week Range:
$61.84
$87.64
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC vs ISRG, BDX, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
73.63 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
378.81 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
192.00 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
231.52 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.26 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-26 | Initiated | William Blair | Mkt Perform |
| Jan-20-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-09-26 | Downgrade | Stifel | Buy → Hold |
| Dec-11-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Alcon stock holds after Q2 sales rose 8 percent - Ad-hoc-news.de
Alcon stock holds in mid-$70 range as Q2 2026 sales rise 8 percent - Ad-hoc-news.de
The Back-to-School Essential Parents Are Overlooking: Eye Exams - Scripps News
Alcon stock edges higher after Q2 2026 sales rise and steady mid-$70 trading level - Ad-hoc-news.de
Alcon stock holds steady as analysts point to upside from latest market cap and valuation context. - Ad-hoc-news.de
What Makes Alcon (ALC) a Bullish Bet? - Yahoo Finance
Resilient Alcon stock holds near $73 as Q2 2026 sales and profit outpace growth in eye-care segments - Ad-hoc-news.de
World Council of Optometry, Alcon, and IACLE Partner to Advance Dry Eye Education - InvisionMag.com
Alcon stock trades around $73 as Q2 2026 profit growth and dry eye push shape expectations - AD HOC NEWS
Alcon stock holds in the low $70s as Q2 2026 growth and dry eye push shape the outlook - AD HOC NEWS
World Council of Optometry, Alcon and IACLE Partner to Advance Dry Eye Education - VisionMonday.com
Alcon (ALC) Q2 2026 Earnings Call Transcript - The Globe and Mail
Alcon stock steadies above $74 as Q2 2026 earnings show mixed profit picture - AD HOC NEWS
Deutsche Bank raises TP for Alcon, but shares down - marketscreener.com
Alcon: A Strong Company Trading Close To Its Intrinsic Value, Buy (NYSE:ALC) - Seeking Alpha
Alcon Inc. (ALC) Stock Analysis: Robust Revenue Growth And A 15.52% Upside Potential - DirectorsTalk Interviews
Stronger Sales But Weaker Earnings Could Be A Game Changer For Alcon (SWX:ALC) - simplywall.st
Alcon stock holds above $74 as investors await August earnings - AD HOC NEWS
Alcon (SWX:ALC) Stock Trades At A Discount On Cash Flow But A Premium On Earnings - Yahoo Finance
Tariff refund boosts Alcon’s second quarter results - WFMZ.com
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - stocktwits.com
Alcon Inc.: Target Price Consensus and Analysts Recommendations | 0A0D | CH0432492467 - marketscreener.com
Alcon stock trades steady as 2026 earnings and eye care demand support valuation - ad-hoc-news.de
UBS Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $102.03 - Moomoo
Alcon: Historical Growth Significantly Understates Potential (ALC) - Seeking Alpha
Alcon (ALC) Institutional Ownership 2026 $ALC - MarketBeat
Alcon stock holds near highs after a 2026 profit lift - AD HOC NEWS
Alcon terminates PowerVision IOL programs, takes $402M write-off - MassDevice
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery? - Yahoo Finance
Bill Ackman’s Pershing Square Just Bought Netflix and 5 Other Stocks. Here’s What Investors Need to Know. - The Motley Fool
Ackman unveils six new investments including Netflix, Visa, Mastercard in portfolio overhaul - Reuters
Resilient Alcon stock holds near $73 as analysts diverge after Q2 strength - AD HOC NEWS
BNP Paribas Downgrades Alcon to Neutral, Cuts PT - marketscreener.com
Resilient Alcon stock holds near recent highs after margin outlook upgrade - AD HOC NEWS
Alcon’s Strong Q2 Left Bernstein More Confident On 2026 - Finimize
Bernstein Updates Alcon Estimates, Price Target After 'Strong' Commercial Execution in Q2 - marketscreener.com
BNP Paribas Exane cuts Alcon stock rating on competitive pressure By Investing.com - Investing.com Australia
BNP Paribas Exane cuts Alcon stock rating on competitive pressure - Investing.com
Alcon Steps Away from PowerVision IOL Program - mddionline.com
ALC Maintains Neutral by JP Morgan -- Price Target Raised to $78 - GuruFocus
Bernstein raises Alcon stock price target on product launches By Investing.com - Investing.com Nigeria
Bernstein raises Alcon stock price target on product launches - Investing.com
ALC Maintained by Mizuho -- Price Target Raised to $85.00 - GuruFocus
Alcon’s New-Product Wave Carries Q2 As It Walks Away From Accommodating IOL Bet - insights.citeline.com
Alcon stock slips as profit reset follows stronger Q2 growth - AD HOC NEWS
Mizuho raises Alcon stock price target to $85 on new products - Investing.com
Key facts: Alcon AG (ALC) Q2 sales +7%; Q3 gross margin to rise - TradingView
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):